Atossa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.About ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C.
CEOSteven C. Quay
CEOSteven C. Quay
Employees15
Employees15
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2008
Founded2008
Employees15
Employees15
ATOS Key Statistics
Market cap108.85M
Market cap108.85M
Price-Earnings ratio-3.74
Price-Earnings ratio-3.74
Dividend yield—
Dividend yield—
Average volume489.83K
Average volume489.83K
High today$0.8469
High today$0.8469
Low today$0.8262
Low today$0.8262
Open price$0.8286
Open price$0.8286
Volume491.81K
Volume491.81K
52 Week high$1.66
52 Week high$1.66
52 Week low$0.5526
52 Week low$0.5526
ATOS News
TipRanks 4d
Buy Rating Supported by Atossa Therapeutics’ Strategic Advancements in Z-endoxifen Development for Breast Cancer TreatmentAtossa Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rat...
TipRanks 5d
Atossa Therapeutics Announces New Regulatory StrategyElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 5d
Atossa Therapeutics has requested Type C meeting with U.S. FDAAtossa Therapeutics (ATOS) announced it has requested a Type C meeting with the U.S. Food and Drug Administration, FDA, to discuss a regulatory strategy aimed a...
People also own
Based on the portfolios of people who own ATOS. This list is generated using Robinhood data, and it’s not a recommendation.